CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 1991; 41:187
doi: 10.3322/canjclin.41.3.187
© 1991 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

CA: A Cancer Journal for Clinicians, Vol 41, Issue 3 187-192, Copyright © 1991 by American Cancer Society


ARTICLES

Unproven methods of cancer management. Laetrile


"Laetrile" is used interchangeably with "amygdalin" to designate natural substances, derived primarily from apricots and almonds, that can release cyanide, which is lethal to living organisms. In the 1920s, Dr. Ernst T. Krebs, Sr., formulated a theory that amygdalin could kill cancer cells. His theory was inconsistent with biochemical facts and has since been modified at least twice by his son, Ernst T. Krebs, Jr. Extensive work has been done by cancer scientists to test the claim that Laetrile fights cancer. Many animal experiments in the 1970s showed a complete lack of tumor killing by Laetrile. Reviews of the medical records of patients whose cancers were claimed to be reduced or cured after Laetrile treatment found insufficient medical evidence to judge Laetrile's efficacy. Finally, in a clinical trial in cancer patients reported in 1982, Laetrile neither caused shrinkage of tumors, nor increased survival time, nor alleviated cancer symptoms, nor enhanced well-being. Several reports in the medical literature document instances in which Laetrile has caused serious, life-threatening toxicity when taken in large doses in the manner prescribed by Laetrile advocates. In light of the lack of efficacy of Laetrile and its demonstrated ability to cause harm, Laetrile should not be used to treat cancer.


This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
J. Bromley, B. G. Hughes, D. C. Leong, and N. A Buckley
Life-Threatening Interaction Between Complementary Medicines: Cyanide Toxicity Following Ingestion of Amygdalin and Vitamin C
Ann. Pharmacother., September 1, 2005; 39(9): 1566 - 1569.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
B. R. Cassileth and G. Deng
Complementary and Alternative Therapies for Cancer
Oncologist, February 1, 2004; 9(1): 80 - 89.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. H. Cohen and D. M. Eisenberg
Potential Physician Malpractice Liability Associated with Complementary and Integrative Medical Therapies
Ann Intern Med, April 16, 2002; 136(8): 596 - 603.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by American Cancer Society.